Analyst Ratings For ARMO Biosciences (NASDAQ:ARMO)
Today, Robert W. Baird initiated coverage on ARMO Biosciences (NASDAQ:ARMO) with a Outperform.
Some recent analyst ratings include
- 2/20/2018-Robert W. Baird initiated coverage with a Outperform rating.
- 2/20/2018-BMO Capital Markets initiated coverage with a Outperform rating.
- 2/20/2018-Jefferies Group initiated coverage with a Buy rating.
Recent Trading Activity for ARMO Biosciences (NASDAQ:ARMO)
Shares of ARMO Biosciences closed the previous trading session at 55.25 up +1.60 2.98% with 57.189998626708984 shares trading hands.